Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19

Enrico Buonamico1, Vitaliano Nicola Quaranta2, Esterina Boniello1

  • 1Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70125, Bari, Italy.

Insights

Elevated C-reactive protein and lymphopenia predict transfer from Respiratory Intermediate Care Units (RICUs) to Intensive Care Units (ICUs) for COVID-19 patients. Early risk factor identification is crucial for better patient stratification.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • COVID-19 pneumonia frequently requires ventilatory support in Respiratory Intermediate Care Units (RICUs) and Intensive Care Units (ICUs).
  • Predictors for transfer from RICU to ICU for acute respiratory distress syndrome (ARDS) in COVID-19 patients lack consensus.
  • Effective patient stratification is needed for optimal resource allocation.

Purpose of the Study:

  • To identify early risk factors for ICU transfer in COVID-19 patients admitted to RICU.
  • To evaluate predictors of transfer from RICU to ICU based on clinical and laboratory data.
  • To improve clinical stratification for patients at risk of ICU admission.

Main Methods:

  • Retrospective observational single-center study of 96 COVID-19 patients.
  • Analysis of demographic data, baseline laboratory profiles, and clinical outcomes.
  • Comparison of patients transferred to ICU versus those remaining in RICU.

Main Results:

  • Elevated C-reactive protein and lymphopenia were the strongest predictors for ICU transfer.
  • Mortality was lower in RICU compared to ICU.
  • Demographics of deceased patients differed between RICU and ICU.

Conclusions:

  • Specific inflammatory markers like C-reactive protein and lymphopenia can predict ICU transfer needs.
  • Enhanced clinical stratification using early risk profiles is vital for RICU patients.
  • Proactive identification of high-risk patients can optimize care during the COVID-19 pandemic.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
447
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
586
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
471
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
431
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
254